cell cycle

Open Access
Attenuative Effect of Diallyl Trisulfide on Caspase Activity in TNF-α-induced Triple Negative Breast Cancer Cells
KONAN J.W. KANGA, LAMBERT H.B. KANGA, PATRICIA MENDONCA, KARAM F.A. SOLIMAN, DOMINIQUE T. FERGUSON, SARAH L. REED and SELINA DARLING-REED

Anticancer Research June 2023, 43 (6) 2393-2405; DOI: https://doi.org/10.21873/anticanres.16407
Open Access
7,8-Diacetoxy-3-(4-methylsulfonylphenyl)-4-phenylcoumarin Induces ROS-dependent Cell Death in the A549 Human Lung Cancer Cell Line
MUSILIYU A. MUSA and QUDUS KOLAWOLE

Anticancer Research March 2023, 43 (3) 1001-1007; DOI: https://doi.org/10.21873/anticanres.16244
You have access
Hypoxia Increases the Proliferative and Metastatic Ability of Canine Mammary Tumor Cells via Up-regulation of TSG-6
TAE-HYEON KIM, JEONG-HWA LEE, JU-HYUN AN, BYUNG-GEE KO, KYEONG-BO KIM and HWA-YOUNG YOUN

Anticancer Research December 2022, 42 (12) 5803-5812; DOI: https://doi.org/10.21873/anticanres.16087
You have access
Determination of Clonogenic Radiosensitivity of HeLa Cells in Early and Late G₁ Phases
KOHKI TOHYAMA, ATSUSHI KAIDA and MASAHIKO MIURA

Anticancer Research November 2022, 42 (11) 5407-5413; DOI: https://doi.org/10.21873/anticanres.16045
You have access
Effect of Aspirin on G₀/G₁ Cell Cycle Arrest and microRNA Signatures in Pancreatic Adenocarcinoma Cells
RYOTA NAKABAYASHI, SHINTARO FUJIHARA, HISAKAZU IWAMA, SAE HAMAYA, TAKAAKI MIZUO, MASAHIRO HIRATA, KOJI FUJITA, TOSHIAKI KONO, DAISUKE NAMIMA, NAOKI FUJITA, HIROKI YAMANA, KIYOYUKI KOBAYASHI, HIDEKI KAMADA, ASAHIRO MORISHITA, HIDEKI KOBARA, MASAFUMI ONO, KEIICHI OKANO and TSUTOMU MASAKI

Anticancer Research August 2022, 42 (8) 4037-4048; DOI: https://doi.org/10.21873/anticanres.15900
You have access
Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma Cells
SAE HAMAYA, SHINTARO FUJIHARA, HISAKAZU IWAMA, KOJI FUJITA, TINGTING SHI, RYOTA NAKABAYASHI, TAKAAKI MIZUO, KEI TAKUMA, MAI NAKAHARA, KYOKO OURA, TOMOKO TADOKORO, SHIMA MIMURA, JOJI TANI, ASAHIRO MORISHITA, HIDEKI KOBARA, MASAFUMI ONO, TAKASHI HIMOTO and TSUTOMU MASAKI

Anticancer Research March 2022, 42 (3) 1263-1275; DOI: https://doi.org/10.21873/anticanres.15593
You have access
Inhibition of Neurotoxicity/Anticancer Activity of Bortezomib by Caffeic Acid and Chlorogenic Acid
REONA MATSUDA, HIROSHI SAKAGAMI, SHIGERU AMANO, YOSUKE IIJIMA, MOTOHIKO SANO, YOSHIHIRO UESAWA, NOBUAKI TAMURA, YOHEI OISHI and HIROSHI TAKESHIMA

Anticancer Research February 2022, 42 (2) 781-790; DOI: https://doi.org/10.21873/anticanres.15536
You have access
Synthesis and Biological Evaluation of Cyclic Analogues from Nitrone LQB-278: A New Potential Antileukemia Compound
RACHELL R.C. THIMOTEO, DEBORA S.S. COSTA, THIAGO MARTINO, JULIO C.F. BARCELLOS, MARSEN G.P. COELHO, PAULO R.R. COSTA, KATIA C.C. SABINO, TATIANA SIMAO, AYRES G. DIAS and GRAÇA JUSTO

Anticancer Research October 2021, 41 (10) 4929-4936; DOI: https://doi.org/10.21873/anticanres.15306
You have access
Combination of CDK4/6 and mTOR Inhibitors Suppressed Doxorubicin-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model: A Translatable Strategy for Recalcitrant Disease
HIROMICHI OSHIRO, YASUNORI TOME, KENTARO MIYAKE, TAKASHI HIGUCHI, NORIHIKO SUGISAWA, FUMINORI KANAYA, KOTARO NISHIDA and ROBERT M. HOFFMAN

Anticancer Research July 2021, 41 (7) 3287-3292; DOI: https://doi.org/10.21873/anticanres.15115
You have access
Targeting CALM2 Inhibits Hepatocellular Carcinoma Growth and Metastasis by Suppressing E2F5-mediated Cell Cycle Progression
SO-YOUNG PARK, YU-RI SEO, MIN JI KO, JAE-HO LEE, KYUNG-SOO CHUN, MIN-JI KIM, YOUNG-KUG CHOO, TAE-JIN LEE and YUN-HAN LEE

Anticancer Research March 2021, 41 (3) 1315-1325; DOI: https://doi.org/10.21873/anticanres.14889

Main menu

User menu

Search

cell cycle

Pages